Unity Biotechnology, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Unity Biotechnology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2016 to 2023.
  • Unity Biotechnology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$6.48M, a 56.2% increase year-over-year.
  • Unity Biotechnology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$21.9M, a 49% increase year-over-year.
  • Unity Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$39.9M, a 10.4% increase from 2022.
  • Unity Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$44.5M, a 26.8% increase from 2021.
  • Unity Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$60.7M, a 35.3% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$39.9M +$4.61M +10.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-15
2022 -$44.5M +$16.3M +26.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-15
2021 -$60.7M +$33.1M +35.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-04-15
2020 -$93.8M -$11.7M -14.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-15
2019 -$82.2M -$5.78M -7.56% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-15
2018 -$76.4M -$31.7M -71.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-23
2017 -$44.7M -$14.3M -46.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-11
2016 -$30.4M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.